Navigation Links
Roche and InterMune Initiate Phase 2b Clinical Trial of RG7227/ ITMN-191 in Patients With Chronic Hepatitis C
Date:8/19/2009

e objective of the Phase 2b randomized, double-blind, placebo-controlled study is to further characterize the safety, tolerability, and antiviral effects of RG7227/ ITMN-191 in triple combination, compared with standard of care (PEGASYS plus COPEGUS).

The two-part study will evaluate treatment regimens of both 12 and 24 weeks. In Part 1 of the study, approximately 210 patients will be randomized to one of four study arms - three of which will receive a 12-week regimen of RG7227/ ITMN-191 at either 300 mg every 8 hours, 600 mg every 12 hours or 900 mg every 12 hours, in combination with PEGASYS and COPEGUS, followed by 12 weeks of therapy with PEGASYS and COPEGUS.* The fourth group will be a control arm receiving PEGASYS and COPEGUS dosed for 48 weeks.

Part 2 of the study, which is expected to begin in the first quarter of 2010, will further evaluate RG7227/ ITMN-191 in a 24-week triple combination regimen with PEGASYS and COPEGUS. Approximately 90 patients will be randomized to one of two study arms in Part 2, either a 24-week regimen of RG7227/ ITMN-191 in combination with PEGASYS and COPEGUS, or a control arm of PEGASYS and COPEGUS dosed for 48 weeks.** Dose selection for Part 2 will be informed by week 4 results generated in Part 1.

RVR results from Part 1 of the study are expected in the first quarter of 2010.

RG7227/ ITMN-191 - Next Steps in Development Program

Roche and InterMune will also initiate in the third quarter a Phase 1 trial combining RG7227/ ITMN-191 with low dose ritonavir to examine the virologic effect of ritonavir-boosted RG7227/ ITMN-191 in once-daily and twice-daily regimens in combination with standard dosing of PEGASYS and COPEGUS in patients chronically infected with HCV genotype 1.

This study builds on promising drug-drug interaction data recently generated in healthy volunteers; a low dose of ritonavir significantly
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Rochester Medical Reports Third Quarter Results
2. Roche Cardiac 200 Offers Rapid Cardiac Diagnostics for the Point of Care
3. Rochester Medical Announces Third Quarter 2009 Earnings Conference Call July 30, 2009
4. Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.
5. Roche Diabetes Care Announces Unique Coaching Program for Diabetes Educators as Part of Long-Term Commitment to Fight the Disease
6. NJLRA Statement in Response to Roches Discontinuation of Accutane(R)
7. Orochem Technologies Acquires Oligonet, a Custom Oligo Synthesis Business
8. Purple Communications Dream Bigger Initiative Honors Rochester Physician and Deaf Community Trailblazer
9. Rochester Medical Corporation Set to Join Russell 3000 Index
10. Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack
11. Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2015)... has released a new blog post explaining what motorcycles ... plan . , Motorcycles can be difficult to ... auto insurance plans. Insurance brokers have gathered a list ... cheaper to insure. , The budget that a ... auto insurance plan that he/she will buy. When comparing ...
(Date:4/19/2015)... has released a new blog post explaining that ... family members. , Accidental death and dismemberment insurance ... in an accident. The policy will cover car accidents ... plan. However, AD&D insurance can also be an independent ... The newly blog post presents the advantages of owning ...
(Date:4/19/2015)... Fla. (PRWEB) April 19, 2015 The ... DO, MPH, MHCM, FACS, as the inaugural winner of ... at its annual meeting, April 18, in Las Vegas, ... Medical Group, vice chairman of the department of surgery ... and Medical Center in Hartford, Connecticut, was instrumental in ...
(Date:4/19/2015)... April 19, 2015 Broccoli sprout extract ... in a small group of healthy human volunteers, the ... with UPMC CancerCenter , announced today at the ... Meeting in Philadelphia. , The promising results will ... will recruit participants at high risk for head and ...
(Date:4/19/2015)... Carinsurancehints.com has released a new blog post providing a ... insurance benefits . , Drivers who were involved in ... information for claiming auto insurance benefits. Exchanging insurance information is ... most of the damages. The newly released blog post explains ... , Drivers can compare online rates and find the best ...
Breaking Medicine News(10 mins):Health News:Buying Auto Insurance for Motorcycles - Models That Are Cheap to Cover! 2Health News:Accidental Death and Dismemberment Insurance Can Provide Financial Security! 2Health News:Dr. Scott Ellner named inaugural Roger Schenke Award winner 2Health News:Dr. Scott Ellner named inaugural Roger Schenke Award winner 3Health News:Preventing Cancer with Broccoli Sprout Extract 2Health News:Preventing Cancer with Broccoli Sprout Extract 3Health News:An Online Guide About Claiming Auto Insurance Benefits After an Accident 2
... properties of bacteria to form barrier against illness , , ... Polytechnic Institute say that have solved the mystery of ... study, published in the current issue of Colloids ... the thermodynamic properties of bacteria in the urinary tract ...
... National Institutes of Health has awarded $128 million to ... Jeffrey Krischer, PhD, to coordinate worldwide studies on the ... a seven-year award, supports Dr. Krischer,s coordination of the ... , The award adds to the $169 million received ...
... Masimo provides Aurora with technology and sensor standardization ... its facilities - creating efficiencies and cost savings, ... inventor,of Pulse CO-Oximetry and Measure-Through-Motion-and-Low-Perfusion Pulse,Oximetry, announced that ... Masimo SET pulse oximetry technology. The integrated health,care ...
... As tens of thousands of Americans,prepare to attend the ... injury or illness -- and how to deal with ... adequate, appropriate medical care in foreign lands can be,daunting, ... themselves,peace of mind," said Angelo Masciantonio, CEO and co-founder ...
... 31 /Xinhua-PRNewswire/ -- Chindex International,Inc. (Nasdaq: CHDX ... products and services in the People,s Republic of ... fiscal 2009 first quarter,financial results on Thursday, August ... a conference call at 8:00 am ET that ...
... Feat could one day lead to tailor-made cells to treat ... -- Scientists have turned skin cells from patients with Lou ... the patients, own neurons. , An unlimited number of these ... a capability which should result in a better understanding of ...
Cached Medicine News:Health News:Study Explains How Cranberries Prevent Urinary Infections 2Health News:University of South Florida receives new multimillion award to assess juvenile diabetes treatments 2Health News:University of South Florida receives new multimillion award to assess juvenile diabetes treatments 3Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 2Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 3Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 4Health News:Aurora Health Care Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology 5Health News:Americans Attending Beijing Olympics Should Plan Ahead for Medical Emergencies 2Health News:Chindex International to Report Fiscal 2009 First Quarter Financial Results 2Health News:Chindex International to Report Fiscal 2009 First Quarter Financial Results 3Health News:Scientists Turn Skin Cells Into Motor Neurons in ALS Patients 2Health News:Scientists Turn Skin Cells Into Motor Neurons in ALS Patients 3
(Date:4/16/2015)... April 16, 2015 Mallinckrodt plc (NYSE: ... today announced that it has completed its acquisition ... approximately $2.3 billion. The Ikaria acquisition extends Mallinckrodt,s ... reach into neonatal critical care with INOMAX ® ... for a highly vulnerable patient population. It also ...
(Date:4/16/2015)... Mich. , April 16, 2015  Diplomat Pharmacy, ... Shannon Beltrand to their senior leadership team ... will be responsible for securing and properly monitoring Diplomat,s ... secure both internally and externally. Additionally, she will play ... "We are very excited to have ...
(Date:4/16/2015)... YORK , April 16, 2015 An ... additional way to generate trimers from the major HIV ... could benefit future clinical development of HIV vaccine candidates ... the critical target on the surface of HIV for ... an important platform for AIDS vaccine discovery, says ...
Breaking Medicine Technology:Mallinckrodt Completes Acquisition Of Ikaria 2Mallinckrodt Completes Acquisition Of Ikaria 3Mallinckrodt Completes Acquisition Of Ikaria 4Mallinckrodt Completes Acquisition Of Ikaria 5Diplomat Names Shannon M. Beltrand as New CISO 2New Method Holds Promise for HIV Vaccine Development 2
... The Mayfield 2000 series radiolucent headrest system ... intraoperative digital subtraction angiography. This system is ... skull clamp and the Mayfield radiolucent base ... designed for patient positioning in the prone ...
Bunnel hand drill with Jacobs chuck, chuck size 4 mm....
Hudson hand drill with extension piece....
Sighting and visualization system of the digital operating suite. The platform that links navigation, and intra-operative imaging to form the ultimate surgical workstation....
Medicine Products: